[EN] CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR [FR] COMPOSÉS DE TRIAZOLE À SUBSTITUTION CYCLOALKYLE EN TANT QU'AGONISTES DU RÉCEPTEUR APJ
[EN] CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR [FR] COMPOSÉS DE TRIAZOLE À SUBSTITUTION CYCLOALKYLE EN TANT QU'AGONISTES DU RÉCEPTEUR APJ
Cycloalkyl substituted triazole compounds as agonists of the APJ receptor
申请人:AMGEN INC.
公开号:US11020395B2
公开(公告)日:2021-06-01
Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: (I) (II) where the definitions of the variables are provided herein.
式 I 和式 II 的化合物、其药学上可接受的盐、前述任何化合物的立体异构体或其混合物是 APJ 受体的激动剂,可用于治疗心血管疾病和其他疾病。式 I 和式 II 的化合物具有如下结构:(I) (II) 变量的定义见本文。
CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
申请人:Amgen Inc.
公开号:EP3541804A1
公开(公告)日:2019-09-25
[EN] CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR<br/>[FR] COMPOSÉS DE TRIAZOLE À SUBSTITUTION CYCLOALKYLE EN TANT QU'AGONISTES DU RÉCEPTEUR APJ
申请人:AMGEN INC
公开号:WO2018093577A1
公开(公告)日:2018-05-24
Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures:(I) (II) where the definitions of the variables are provided herein.